Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AVAH | PGEN |
|---|---|---|
| Price | $12.34 | $7.68 |
| Change today | ▼ 0.24% | ▼ 0.84% |
| Market cap | $2.69B | $2.75B |
| Return, 3 months | +28.5% | +39.3% |
| Return, year to date | +51.0% | +83.6% |
| Return, 1 year | +45.0% | +144.4% |
| P/E (TTM) | 9.8 | -7.2 |
| P/B | 9.4 | 62.9 |
| P/E percentile vs own 5y | 80th | 8th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +21.6% | +95.4% |
| Analyst buy share | 71% | 100% |
| RSI (14) | 42 | 53 |
| 30-day volatility | 31.9% | 56.1% |
| Max drawdown, 1 year | -39.4% | -40.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
